Charlie Qi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 01/08/2020 | - |
| Roche Global Product Development Center | Corporate Officer/Principal | 01/08/2017 | - |
Career history of Charlie Qi
Former positions of Charlie Qi
| Companies | Position | Start | End |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/05/2012 | 01/08/2017 |
Statistics
International
| China | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
| Roche Global Product Development Center | |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Charlie Qi
- Experience
